The developing landscape of diabetes treatment is witnessing a exciting shift, driven by new incretin-based therapies. Currently, semaglutide has gained considerable attention, but rival medications like tirzepatide, https://agnesiwyq844003.blog-gold.com/58825690/the-future-of-diabetes-comparing-tirzepatide-semaglutide-retatrutide-and-cagrilintide